BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $98,227 | -4.3% | 100,000 | 0.0% | 0.00% | – |
Q1 2023 | $102,598 | -3.3% | 100,000 | 0.0% | 0.00% | – |
Q4 2022 | $106,130 | +7.2% | 100,000 | 0.0% | 0.00% | – |
Q3 2022 | $99,000 | 0.0% | 100,000 | 0.0% | 0.00% | – |
Q2 2022 | $99,000 | -1.0% | 100,000 | 0.0% | 0.00% | – |
Q1 2022 | $100,000 | -67.9% | 100,000 | -66.4% | 0.00% | -100.0% |
Q4 2021 | $312,000 | -40.0% | 298,000 | -41.3% | 0.00% | 0.0% |
Q3 2021 | $520,000 | -18.2% | 508,000 | -17.3% | 0.00% | 0.0% |
Q2 2021 | $636,000 | -31.4% | 614,000 | -33.0% | 0.00% | -50.0% |
Q1 2021 | $927,000 | +33.6% | 916,000 | +41.6% | 0.00% | 0.0% |
Q4 2020 | $694,000 | +46.7% | 647,000 | +43.5% | 0.00% | +100.0% |
Q3 2020 | $473,000 | +15.9% | 451,000 | +35.0% | 0.00% | 0.0% |
Q2 2020 | $408,000 | +16.6% | 334,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $350,000 | -34.5% | 334,000 | -33.9% | 0.00% | -50.0% |
Q4 2019 | $534,000 | +7.7% | 505,000 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $496,000 | -5.3% | 505,000 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $524,000 | +1.4% | 505,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $517,000 | – | 505,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
IRON Financial LLC | 275,000 | $295,000 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |